ZNF317
Zinc finger protein 317
Also known as: ZN317_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PQ6
- Gene
- ZNF317
- Ensembl
- ENSG00000130803
- Chromosome
- 19
- Canonical length
- 595 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
595 residues, UniProt reviewed canonical sequence.
>Q96PQ6|ZNF317
1 MAALSPTFAT STQDSTCLQD SEFPVSSKDH SCPQNLDLFV CSGLEPHTPS VGSQESVTFQ
61 DVAVDFTEKE WPLLDSSQRK LYKDVMLENY SNLTSLGYQV GKPSLISHLE QEEEPRTEER
121 GAHQGACADW ETPSKTKWSL LMEDIFGKET PSGVTMERAG LGEKSTEYAH LFEVFGMDPH
181 LTQPMGRHAG KRPYHRRDYG VAFKGRPHLT QHMSMYDGRK MHECHQCQKA FTTSASLTRH
241 RRIHTGEKPY ECSDCGKAFN DPSALRSHAR THLKEKPFDC SQCGNAFRTL SALKIHMRVH
301 TGERPYKCDQ CGKAYGRSCH LIAHKRTHTG ERPYECHDCG KAFQHPSHLK EHVRNHTGEK
361 PYACTQCGKA FRWKSNFNLH KKNHMVEKTY ECKECGKSFG DLVSRRKHMR IHIVKKPVEC
421 RQCGKTFRNQ SILKTHMNSH TGEKPYGCDL CGKAFSASSN LTAHRKIHTQ ERRYECAACG
481 KVFGDYLSRR RHMSVHLVKK RVECRQCGKA FRNQSTLKTH MRSHTGEKPY ECDHCGKAFS
541 IGSNLNVHRR IHTGEKPYEC LVCGKAFSDH SSLRSHVKTH RGEKLFVSSV WKRLQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF317 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 25 nTPM
- spleen: 24 nTPM
- skin: 22 nTPM
- liver: 21 nTPM
- kidney: 20 nTPM
- cerebellum: 19 nTPM
Single-cell type
- tuft cells: 46 nCPM
- erythrocyte progenitors: 26 nCPM
- megakaryocyte-erythroid progenitors: 24 nCPM
- microglia: 22 nCPM
- b-cells: 21 nCPM
- pancreatic acinar cells: 20 nCPM
Immune cell
- NK-cell: 23 nTPM
- T-reg: 23 nTPM
- memory B-cell: 21 nTPM
- MAIT T-cell: 21 nTPM
- basophil: 19 nTPM
- naive CD8 T-cell: 18 nTPM
Brain region
- cerebral cortex: 15 nTPM
- white matter: 15 nTPM
- cerebellum: 15 nTPM
- choroid plexus: 15 nTPM
- thalamus: 14 nTPM
- basal ganglia: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.33
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF317 as an antibody target. Whether an autoantibody or antibody against ZNF317 could matter depends on whether native ZNF317 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF317 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF317 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...